Scientists probe immune cells in pneumonia to unlock ARDS secrets

NCT ID NCT03379207

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how certain immune cells, called non-conventional T cells, behave in patients with severe pneumonia and acute respiratory distress syndrome (ARDS). Researchers collected blood and airway samples from 258 intensive care unit patients to track these cells over time. The goal was to better understand the immune response that can lead to worsening illness, which may help improve future treatments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could help doctors better understand why some pneumonia cases turn severe, potentially pointing to new ways to predict or treat complications like ARDS.
What could go wrong
This is an observational study that was terminated early, so results may be limited. It does not test a treatment, so direct patient benefits are not guaranteed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE RESPIRATORY DISTRESS SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University Hospitakl of TOURS Département of Pneumonia

    Tours, 37044, France

  • University Hospital -Bretonneau - Intensive Care

    Tours, 37044, France

  • University Hospital of Tours; INSERM CIC 1415

    Tours, 37044, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.